Cresco Labs (CL.CN) Stock Analysis & Winston Score
Cresco Labs is one of the largest cannabis companies in the United States. It grows, processes, and sells marijuana products — including flower, vapes, concentrates, and edibles — under brands like Cresco and Mindy's. It sells to both medical patients and adult recreational consumers through its own retail dispensaries and through wholesale to other licensed cannabis stores. Cresco makes money by selling cannabis products wholesale to dispensaries across multiple states and through its own retail locations. It operates in key markets including Illinois, Pennsylvania, Ohio, and Florida, giving it a multi-state footprint that smaller operators struggle to match. The company's main competitive advantage is its large wholesale distribution network, which reaches hundreds of third-party dispensaries. The biggest risk it faces is ongoing federal cannabis prohibition, which blocks access to normal banking, creates heavy state-by-state tax burdens, and prevents interstate commerce — all of which squeeze profitability and limit how fast the business can grow.
Winston Score: 27/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (13/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (1/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (6/15)
Key Facts
Price: 1.13 CAD
Market Cap: 400M CAD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Canadian Securities Exchange

